FDA okays glycopyrrolate/formoterol combo for COPD

The Food and Drug Administration has approved glycopyrrolate and formoterol fumarate inhalation aerosol for long-term maintenance treatment of airflow obstruction in patients with chronic obstructive...
Source: Family Practice News - Category: Primary Care Source Type: news